Pregnancy striae. Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group 1: Rose damascene oil. The 10% rose damascene oil at the base of the cream will be produced by a pharmacognosist at the Biotechnology Research Center and it will be
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Gestational age of 16-20 weeks Having a single live fetus Nulliparity Being at the age of 18-35 years Body mass index of 18.5-25 kg /m2 Being literate (at least writing and reading skills)
Exclusion criteria
Exclusion criteria: The use of other herbal or chemical drugs on the affected area Sensitivity to rose oil and sesame oil and not being able to use the drug twice daily Taking corticosteroids previous striae Surgical scar on the abdomen Having chronic diseases Having adrenal glands diseases Presence of skin disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence rate of gestational striae. Timepoint: Evaluation of incidence in 35-37 weeks of gestation. Method of measurement: Davey method.;Incidence rate of itching. Timepoint: The incidence of pruritus in 35-37 weeks of gestation. Method of measurement: Kamini method.;Severity of gestational striae. Timepoint: Evaluation of severity of striae in 35-37 weeks of gestation. Method of measurement: Davey method.;Severity of itching. Timepoint: Evaluation of severity of pruritus in 35-37 weeks of gestation. Method of measurement: Kamini method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction of medication use. Timepoint: 35-38 weeks of gestation. Method of measurement: Satisfaction Questionnaire.;Side effects. Timepoint: 35-38 weeks of gestation. Method of measurement: Side effects Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzizeh Farshbaf-khalili
Tabriz University of Medical Sciences
Outcome results
None listed